Isabelle de Cremoux

Président du directoire/CEO de @SeventureP

[Isabelle de Cremoux @IdeCremoux]

Congrats @KariusInc for your series C round.

[Karius @KariusInc]

We've raised $100M in new funding co-led by @KhoslaVentures, @5AMVentures and @GildeHealthcare, with new and existing investors returning to participate. Thanks for your continued support in our fight against #infectiousdisease and #AMR resistance.

https://t.co/QkshDYbZjL

[Tansu Yegen @TansuYegen]

🎤 Mohammed Qahtani, a Saudi engineer, delivered one of the most impactful speeches ever, winning the Toastmasters World Championship. He showcased the strength found in words...

[Seventure Partners @SeventureP]

Cession de @TargEDys à #Biocodex. Seventure & le fonds Health for life capital™ ont soutenu les 2 fondateurs #PierreDechelotte et #SergueiFetissov dès la création de la société pour développer des modulateurs du #microbiote innovants (souche Hafnia Alvei 4597) @IdeCremoux

[Le Déméter @Le_Demeter]

Proposition de loi "Bien #vieillir" en cours en France 🧑‍🦳 L'occasion de rappeler que #santé et #alimentation sont liées !

Le Déméter traite ces sujets👇
Microbiote, la révolution du siècle: https://t.co/9Gi0DCGlrG 🔎
Bien se nourrir pour bien vieillir: https://t.co/n6Shrwv9Ss 🍴

[Isabelle de Cremoux @IdeCremoux]

Une belle étape pour #Polaris et bravo à son équipe !

C'est avec plaisir que je continue à vous accompagner en gardant mon rôle au conseil d'administration.

[Seventure Partners @SeventureP]

[Health for Life Capital Portfolio] Seventure Partners annonce la cession de #Polaris pionnière des ingrédients santé (#omega3) TRI de + de 150% https://t.co/78IZuwpTF1 @CereaPartners @IdeCremoux
#Microbiome #Nutrition #Ingredients #Sante

[Isabelle de Cremoux @IdeCremoux]

Congrats to #Polaris and the whole team.

Let's keep on writing the future of the company. I'll proudly continue to serve as a board member with this aim.

#Microbiome #Nutrition #Ingredients #Health

[Seventure Partners @SeventureP]

[Health for Life Capital Portfolio] Seventure Partners announces the sale of #Polaris, a pioneer in health #ingredients (#omega3) based on #microalgae oils, with an IRR of more than 150%. @CereaPartners @IdeCremoux
#Microbiome #Nutrition #Ingredients #Health #Investement #LBO

[MaaT Pharma @MaaT_Pharma]

Nous recherchons un nouveau #membre pour rejoindre notre département #financier ! Connaissez-vous quelqu’un intéressé ?
👉 https://t.co/EMz83cV6Oy

#emploi #investisseur #santé #biotech #microbiote #recrutement

[MaaT Pharma @MaaT_Pharma]

We are looking for a new #team member to join the #finance department!
Know anyone interested?
👉 https://t.co/WC8gp5xSlM

#jobopening #biotech #microbiome #hiring #careers

[Isabelle de Cremoux @IdeCremoux]

February 17, 2023: @MaaT_Pharma Completes a Capital Increase of approximately €12.7 Million with the Support of Current Shareholders #microbiome #healthforlifecapital @SeventureP

https://t.co/a6yYQnD5ls

[Isabelle de Cremoux @IdeCremoux]

@MaaT_Pharma réalise une augmentation de capital d'environ 12,7 ME avec le soutien de ses actionnaires principaux #microbiome #healthforlifecapital @SeventureP https://t.co/53OSUqoj1R

[Seventure Partners @SeventureP]

[Health for Life Capital portfolio BIG NEWS!] @SioltaThera Announces First Newborn Dosed in Their Phase 2 ADORED Study Evaluating a Potential First-In-Class Live Biotherapeutic Product for the Prevention of Atopic Diseases https://t.co/ZZ38z50Zy4 @IdeCremoux #Microbiome #Impact

[Enterome @EnteromeSA]

Our major strategic R&D collaboration with @NestleHSci targets the co-development of #EndoMimics™ compound, EB1010, alongside the creation of #AllerMimics™ immunotherapies to treat #foodallergies & inflammatory bowel disease (#IBD).
Click to read the PR:
https://t.co/tbtwRDzxn2

[Seventure Partners @SeventureP]

[Health for Life Capital portfolio] 👋 @EnteromeSA signs major strategic R&D collaboration with @Nestle Health Science to develop & commercialize new AllerMimics™ and EndoMimics™ #immunotherapies for #food #allergies and #IBD https://t.co/o5WW8d6pCq @IdeCremoux

[Seventure Partners @SeventureP]

[Health for Life Capital portfolio] @EnteromeSA presents proof-of-concept immune response data and first clinical data from Phase 1/2 trial with EO2401, a first-in-class OncoMimics™ therapeutic #cancer vaccine for #glioblastoma, at #ASCO2022 https://t.co/jKb5uTGKsk

[Seventure Partners @SeventureP]

👋Interesting article published on @Davos website "Blue economy: how business leaders and scientists are improving ocean health" 👉 https://t.co/25036i6wCg #BlueEconomy is a major topic where Seventure is strongly engaged with dedicated fund #BlueForwardFund @IdeCremoux

[Seventure Partners @SeventureP]

#Sportech : Belle journée d’échanges avec les CEOs des sociétés de notre portefeuille #SportPerformanceCapital. Merci @myclim8 @Hardloopfr @kinomap @MOVE_N_SEE @SkillCorner @SportEasy @freejumpsystem @geovelofr @brunorivet1 @IdeCremoux https://t.co/Xt9xw2ZPGK

[Bernat Olle 🇺🇦 @bernatolle]

Today we published at @cellhostmicrobe the results of a Phase 1 study of @vedantabio‘s lead candidate VE303 (for C. difficile infection), with a focus one studying pharmacokinetics (PK) and pharmacodynamics (PD) of this defined bacterial consortium. https://t.co/yRu8RQ2Hps🧵 /1

[Seventure Partners @SeventureP]

[marché] @Danone @sanofi @LOrealGroupe : les géants industriels à l'assaut du #microbiote https://t.co/mFamjtKRid @BPI_France @IdeCremoux

[Seventure Partners @SeventureP]

Backing the #Microbiome: The Investor Perspective with our CEO @IdeCremoux 👉https://t.co/L674OyLGEI Big thanks to @hl_albert @Inside_PM

[Geovelo @geovelofr]

Geovelo lève 3,8M€ pour contribuer au développement du vélo partout dans le monde, grâce à son app grand public gratuite, et à son bouquet de services dédié aux collectivités.
Merci @SeventureP et @BanqueDesTerr de nous accompagner dans cette aventure ! https://t.co/X0Ho3tkOfw